Pandemics from various viruses make natural organisms face challenges over and over
again. Therefore, new antiviral drugs urgently need to be found to solve this problem …

Respiratory syncytial virus (RSV), a member of the Pneumoviridae family, can cause severe
acute lower respiratory tract infection in infants, young children, immunocompromised …

Respiratory syncytial virus (RSV) infection is a major cause of morbidity in children.
However, its disease burden remains poorly understood, particularly outside of the hospital …

The restrictive measures adopted worldwide against SARS-CoV-2 produced a drastic
reduction in respiratory pathogens, including RSV, but a dramatic rebound was thereafter …

Background Several immunisation candidates against RSV are in late-stage clinical trials.
To evaluate the benefits of a potential vaccination programme, both economic and health …

Innate immunity is the first line of the host immune system to fight against infections. Natural
killer cells are the innate immunity lymphocytes responsible for fighting against virus …

The recent spike in the instances of complex physiological host-microbe interactions has
raised the demand for developing in vitro models that recapitulate the microbial …

Respiratory syncytial virus (RSV) is a highly contagious respiratory virus that can cause mild
to severe illness in children. It is the leading cause of lower respiratory tract infections (LRTI) …

Intercellular contacts between epithelial cells are established and maintained by the apical
junctional complexes (AJCs). AJCs conserve cell polarity and build epithelial barriers to …

Respiratory viral infections are common respiratory diseases. Influenza viruses, RSV and
SARS-COV2 have the potential to cause severe respiratory infections. Numerous studies …